|
Die USPSTF hatte sich in ihrer Richtline auf die Richtlinien von anderen Organisationen bezogen. Das wäre für mich der erste valide Anlaufspunkt, welche weiteren Richtlinienorganisationen es noch für Darmkrebs-Vorsorge gibt.
Recommendations of Others
“Many organizations have issued guidelines concerning screening for colorectal cancer. All of the following recommendations apply to average-risk adults 50 years and older.
-> In 2008, the American Cancer Society, American College of Radiology, and the US Multi-Society Task Force (including the American Gastroenterological Association, American College of Gastroenterology, and American Society for Gastrointestinal Endoscopy) jointly issued recommendations. They prioritized flexible sigmoidoscopy every 5 years, colonoscopy every 10 years, double-contrast barium enema every 5 years, and CT colonography every 5 years as preferred tests “designed to both prevent and detect cancer” if resources are available but also recommended annual high-sensitivity gFOBT or FIT-DNA testing (interval uncertain).8 Shortly thereafter, the American College of Gastroenterology released an independent guideline recommending colonoscopy every 10 years as the single preferred screening strategy. It stated that if colonoscopy is not available or is unacceptable to a patient, recommended alternative strategies include flexible sigmoidoscopy every 5 to 10 years or CT colonography every 5 years (preferred) or annual FIT, annual Hemoccult II SENSA, or FIT-DNA testing every 3 years (acceptable).28
-> In 2012, the National Comprehensive Cancer Network recommended colonoscopy every 10 years as the preferred screening strategy if available; otherwise, it recommended annual gFOBT or FIT, with or without flexible sigmoidoscopy, every 5 years or flexible sigmoidoscopy alone every 5 years as secondary approaches to screening.29
-> In 2015, the American College of Physicians recommended that average-risk adults aged 50 to 75 years should be screened for colorectal cancer by 1 of 4 strategies: 1) annual high-sensitivity gFOBT or FIT, 2) flexible sigmoidoscopy every 5 years, 3) high-sensitivity gFOBT or FIT every 3 years plus flexible sigmoidoscopy every 5 years, or 4) colonoscopy every 10 years. It advised that average-risk adults younger than 50 years, older than 75 years, or with an estimated life expectancy of less than 10 years should not be screened.30 The American Academy of Family Physicians is in the process of updating its guidelines.31
-> In 2016, the Canadian Task Force on Preventive Health Care recommended that adults aged 50 to 59 years (weak recommendation) and 60 to 74 years (strong recommendation) be screened for colorectal cancer with gFOBT or FIT every 2 years or flexible sigmoidoscopy every 10 years. It recommended against screening in adults 75 years and older (weak recommendation) and using colonoscopy as a primary screening test (weak recommendation).32”
Quelle: 04.10.2016 https://www.uspreventiveservicestaskforce.org/...ancer-screening2#tab
Am 09.06.2017 gab es noch ein Update der USPSTF:
Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer
Abstract
This document updates the colorectal cancer (CRC) screening recommendations of the U.S. Multi-Society Task Force of Colorectal Cancer (MSTF), which represents the American College of Gastroenterology, the American Gastroenterological Association, and The American Society for Gastrointestinal Endoscopy. ...
We suggest that the Septin9 serum assay (Epigenomics, Seattle, Wash) not be used for screening.
Quelle https://www.ncbi.nlm.nih.gov/pubmed/28555630; 09.06.2017 -- Am J Gastroenterol. 2017 Jul;112(7):1016-1030
Ich würde mit meinem laienhaften Verstädnis sagen: ACS ist nicht für den Epi proColon Test und USPSTF sogar dagegen.
MfG J:)E
|
Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.
Zurück geht es hier.
Thread abonnieren
